Study of careful monitoring for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study follows people with early-stage prostate cancer who choose active surveillance instead of immediate treatment. It aims to see how monitoring with repeat prostate biopsies and follow-up works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer must be confirmed by a biopsy (adenocarcinoma found on tissue).
- Your cancer should be early/localized (not known to have spread based on standard staging).
- You have not had any prostate cancer treatment before (no surgery, radiation, hormone therapy, or chemotherapy).
- You must be able to do repeat prostate biopsies as part of active surveillance and show up for follow-up.
- Your diagnosis should be within the last 3 years, and your biopsy history must meet specific limits (no more than 2 total biopsies for this diagnosis, and enough repeat biopsies if it’s older than 1 year).
- Your biopsy samples must include at least 10 tissue cores.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special MRI scans to help track low-risk prostate cancer while you stay on active surveillance (meaning no immediate treatment). It may help your care team better understand changes in the cancer over time.
This trial tests how a special MRI scan (with multiple measurements) may help men with low-risk prostate cancer who are monitoring it closely instead of treating right away. It may help doctors better understand the cancer’s status during active surveillance.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.